Loop Capital initiated coverage of Lionsgate Studios (LION) with a Hold rating and $8 price target The firm is not expecting an acquisition in the near term and believes the company is fairly valued on current fundamentals. Post the separation from Starz, Lionsgate is a well positioned, pure-play, intellectual property studio, but management’s focus is to continue growing the business, and the board has instituted a one-year poison pill, that could become a three-year poison pill if approved by shareholders, the analyst tells investors in a research note. Loop sees the company’s fiscal 2026 as a rebuilding year will lower than normal backend profits from the prior year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LION:
- Lionsgate Studios initiated with a Hold at TD Cowen
- Mnuchin’s Liberty Strategic Capital raises Lionsgate Studios stake to 12.6%
- Lionsgate Studios price target lowered to $10 from $13 at Citi
- Lionsgate Studios price target lowered to $8 from $8.50 at Morgan Stanley
- Promising Growth and Undervalued Potential: A Buy Recommendation for Lionsgate Studios